RESUMO
BACKGROUND AND OBJECTIVES: Individuals with epilepsy have increased risk of suicidal ideation (SI) and behaviors when compared with the general population. This relationship has remained largely unexplored in adolescents. We investigated the prevalence of suicidality in adolescents with newly diagnosed focal epilepsy within 4 months of treatment initiation and over the following 36 months. METHODS: This was a post hoc analysis of the enrollment and follow-up data from the Human Epilepsy Project, an international, multi-institutional study that enrolled participants between 2012 and 2017. Participants enrolled were 11-17 years of age within 4 months of treatment initiation for focal epilepsy. We used data from the Columbia Suicide Severity Rating Scale (C-SSRS), administered at enrollment and over the 36-month follow-up period, along with data from medical records. RESULTS: A total of 66 adolescent participants were enrolled and completed the C-SSRS. At enrollment, 14 (21%) had any lifetime SI and 5 (8%) had any lifetime suicidal behaviors (SBs). Over the following 36 months, 6 adolescents reported new onset SI and 5 adolescents reported new onset SB. Thus, the lifetime prevalence of SI within this population increased from 21% to 30% (14-20 adolescents), and the lifetime prevalence of SB increased from 8% to 15% (5-10). DISCUSSION: The prevalence of suicidality in adolescents with newly diagnosed focal epilepsy reported in our study is consistent with previous findings of significant suicidality observed in epilepsy. We identify adolescents as an at-risk population at the time of epilepsy diagnosis and in the following years.
Assuntos
Epilepsias Parciais , Ideação Suicida , Humanos , Adolescente , Masculino , Feminino , Epilepsias Parciais/epidemiologia , Epilepsias Parciais/psicologia , Epilepsias Parciais/diagnóstico , Prevalência , Criança , Seguimentos , Suicídio/estatística & dados numéricos , Suicídio/psicologiaRESUMO
Background: Epilepsy, characterized by recurrent unprovoked seizures, poses a significant global burden on individuals and healthcare systems. Accurate identification of underlying causes is vital for optimal intervention. However, studies reveal a lack of standardized approaches, potentially resulting in unnecessary investigations. Objective: We aimed to highlight the importance of avoiding unnecessary testing to minimize healthcare costs and resource waste. Methods: In the Emergency Department of King Fahd Hospital of the University (KFUH) in Alkhobar, a retrospective cross-sectional study encompassed 190 patients presenting with seizures from January 1, 2020, to December 31, 2022. The study aimed to elucidate the epidemiological profile and distinguish clinical and demographic factors between new onset seizures and known cases. Results: The study included 190 epilepsy cases, with 51.1% known and 48.9% new onset. Generalized tonic-clonic seizures were prominent (43.2%), and non-compliance (24.2%) was a leading cause. New onset seizures were associated with abnormal CT findings (p=0.025), drug use (74.2%), and intoxication (6.5%). Demographically, Saudis showed higher new onset prevalence (82.8%, p=0.001). Conclusion: The average length of stay was 5.93 hours, and the distribution of new vs. known cases was nearly equal among the 190 patients. Laboratory findings showed no significant associations with either group, mostly falling within the normal range. To optimize care further, we recommend continued refinement of protocols, emphasis on medication compliance.
Assuntos
Serviço Hospitalar de Emergência , Epilepsia , População do Oriente Médio , Humanos , Anticonvulsivantes/uso terapêutico , Estudos Transversais , Serviço Hospitalar de Emergência/estatística & dados numéricos , Epilepsias Parciais/epidemiologia , Epilepsia/epidemiologia , Epilepsia/etiologia , Epilepsia Generalizada/epidemiologia , Epilepsia Tônico-Clônica/epidemiologia , População do Oriente Médio/estatística & dados numéricos , Estudos Retrospectivos , Arábia Saudita/epidemiologia , Convulsões/epidemiologia , Convulsões/etiologiaRESUMO
Introducción: El papel de la estimulación crónica intermitente del nervio vago (ECINV) en el tratamiento de la epilepsia refractaria está evolucionando y requiere precisarse mediante la descripción de resultados, efectos adversos y complicaciones en poblaciones específicas. Material y métodos: Se seleccionaron los pacientes con epilepsia refractaria sometidos a ECINV con mínimo 12 meses de seguimiento, utilizando estadística descriptiva e inferencial para valorar el efecto sobre la frecuencia e intensidad de las crisis, memoria, ánimo, estado de alerta, recuperación postictal y calidad de vida (escala subjetiva, cuestionario QoLIE-31), y los factores (sexo, edad, tiempo de evolución, número/tipo crisis, parámetros de estimulación) asociados a la respuesta clínica. Se describen los parámetros de estimulación usados, empleo del magneto, complicaciones y efectos adversos. Resultados: Se seleccionaron 35 pacientes, edad de cinco a 48 años, 18 con epilepsia parcial, 17 con generalizada. No hubo complicaciones, infección o alteración de la cicatrización en los procedimientos quirúrgicos. La reducción promedio en crisis fue de 55.65 % (p < 0.001). En epilepsias generalizadas hubo 58.8 % de respondedores y 88.9 % en parciales. Cuatro sujetos presentaron mejoría > 90 %, con control total; en dos pacientes aumentó la frecuencia de las crisis. La respuesta al tratamiento fue buena subjetivamente en 33 pacientes. La calificación global de QoLIE-31 aumentó 12.6 puntos (p = 0.020). Solo el tipo de crisis se asoció con la respuesta clínica. Los efectos adversos fueron transitorios y respondieron al cambio de parámetros de estimulación. Conclusiones: la ECINV es segura, bien tolerada y eficaz para el tratamiento paliativo en casos seleccionados de crisis parciales y generalizadas multifocales refractarias.
BACKGROUND: The role of vagal nerve stimulation (VNS) in the treatment of refractory epilepsy is still evolving and requires precision through extensive description of acute and chronic results, adverse effects and complications in specific populations. METHODS: We selected patients with refractory epilepsy subjected to VNS who had completed at least a 12-month followup. Descriptive and inferential statistics were used to review and assess the effects of VNS on seizure frequency/intensity, memory, alertness, mood, postictal recovery, and quality of life (subjective scale, QoL IE-31 inventory) as well as factors (gender, age, age of onset, time of surgery, stimulation parameters, seizure frequency and type) associated with clinical response. We describe stimulation parameters, complications and adverse effects compared to other series. RESULTS: We selected 35 patients with an age range of 5-48 years; 18 patients presented partial epilepsy and 17 generalized epilepsy. All procedures and wound healing were uneventful, and no infections were reported. Median reduction in seizure frequency was 55.65% (p <0.001). Four patients showed improvement of >90%. Two patients became seizure free, whereas seizure frequency increased in two patients. The subjectively qualified response to treatment was good in 33 patients. The mean global increase in the QoLIE-31 Scale was 12.6 (p = 0.020). Improvements in memory, mood, alertness and postictal recovery period were documented. Only seizure type showed statistically significant association with clinical response. Adverse effects were transitory and responded to changes in stimulation parameters. CONCLUSIONS: VNS is a safe, feasible, well-tolerated and effective palliative treatment in appropriately selected cases of refractory partial and multifocal generalized seizures.
Assuntos
Humanos , Criança , Adolescente , Adulto Jovem , Epilepsia/terapia , Estimulação do Nervo Vago/métodos , Afeto , Conscientização , Anticonvulsivantes/uso terapêutico , Cuidados Paliativos , Terapia Combinada , Eletrodos Implantados , Epilepsia Generalizada/tratamento farmacológico , Epilepsia Generalizada/epidemiologia , Epilepsia Generalizada/terapia , Epilepsia/tratamento farmacológico , Epilepsias Parciais/tratamento farmacológico , Epilepsias Parciais/epidemiologia , Epilepsias Parciais/terapia , Estimulação do Nervo Vago/efeitos adversos , Estimulação do Nervo Vago/instrumentação , Memória , México/epidemiologia , Qualidade de Vida , Estudos Retrospectivos , Resultado do TratamentoRESUMO
El objetivo del presente trabajo fue caracterizar un grupo de pacientes con epilepsias focales, según aspectos clínicos y electroencefalográficos. Se realizó un estudio descriptivo y prospectivo de 185 niños con diagnóstico de epilepsia focal (2 o más crisis epilépticas no provocadas), con edades entre un mes y 14 años, que fueron hospitalizados en el Departamento de Neuropediatría del Hospital William Soler entre diciembre de 2001 y diciembre de 2003. La edad media de inicio de la primera crisis epiléptica fue de 5 años. El tipo de crisis epiléptica focal más frecuente fue la simple (49,2 por ciento). El 48,6 por ciento de los niños presentó etiología idiopática y el 33,0 por ciento sintomática. Los factores de la etiología sintomática más frecuentes fueron los prenatales (56,2 por ciento). El 91,4 por ciento de los pacientes presentó electroencefalogramas iniciales interictales anormales. El electroencefalograma focal se observó en el 37,3 por ciento de los niños y el multifocal en el 24,9 por ciento. El síndrome epiléptico más frecuente fue la epilepsia benigna con puntas centrotemporales (5,9 por ciento). Los niños con epilepsia focal tienen variadas manifestaciones clínicas y electroencefalográficas, y en la mayoría de los pacientes no es posible identificar un síndrome epiléptico.
The aim of present paper was to characterize a group of patients presenting with focal epilepsies by clinical and electroencephalographic features. Authors made a descriptive and cross-sectional study in 185 children diagnosed with focal epilepsy (two or more non-provoked epilepsy crises), aged from one month to 14, admitted in Neurology Department of William Soler Children Hospital between December 2001 to December 2003. Mean age of the first epilepsy crisis was at 5 years. The more frequent type of focal epilepsy crisis was the simple one (49, 2 percent). The 48, 6 percent of children presented with a idiopathic origin, and the 33, 0 percent if symptomatic one. The more frequent factors of symptomatic origin were the prenatal ones (56, 2 percent). The 91, 4 percent of patients had abnormal interictal initial electroencephalograms. The focal electroencephalogram was observed in the 37, 3 percent of children, and the multifocal one in the 24, 9 percent. The more frequent epileptic syndrome was the benign epilepsy with central-temporal waves (5, 9 percent). Children presenting with epilepsy have many clinical and electroencephalographic manifestations and in most of patients it is not possible to identify an epilepsy syndrome.